{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:55:28Z","timestamp":1780394128942,"version":"3.54.1"},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder with unknown etiology. The absence of reliable biochemical and imaging markers often delays diagnosis and limits treatment effectiveness. As metabolic reprogramming is increasingly recognized as a hallmark of ALS, a comprehensive untargeted metabolomics analysis was employed to identify critical metabolic perturbations in ALS and explore novel candidate biomarkers with potential utility in clinical diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Plasma from two independent cohorts comprising 399 participants (170 ALS patients, 200 healthy controls, and 29 ALS-unrelated neurological disease controls) was included. Cohort 1 was recruited from Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital (April 2020\u2013September 2022), and cohort 2 from Sichuan Academy of Sciences-Sichuan Provincial Hospital, Ruijin Hospital, Shanghai Jiaotong University Affiliated Sixth People\u2019s Hospital, and The First Affiliated Hospital of Dalian Medical University (October 2022\u2013February 2023). Gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-mass spectrometry (LC-MS)-based metabolomics approaches were used to identify metabolic alterations and potential diagnostic biomarkers for ALS. Complementary multivariable and univariable statistical approaches were applied to characterize disease-specific metabolic reprogramming in ALS. In addition, the receiver operating characteristic (ROC) curve was used to assess the discriminatory power of differential metabolites, and binary logistic regression analysis was used to construct a multivariate biomarker model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Metabolic changes of ALS were mainly observed in amino acids, fatty acyls , and purines. Inosine and hypoxanthine were found to be the most significantly and critically dysregulated metabolites in ALS. Aminoacyl-transfer ribonucleic acid (tRNA) biosynthesis and amino acid metabolism were regarded as the most significantly perturbed pathways. Across both cohorts, 26 metabolites were consistently changed. Notably, a biomarker panel comprising hypoxanthine, inosine, and trigonelline was constructed using binary logistic regression, achieving excellent diagnostic performance in distinguishing ALS from controls, with an area under the ROC curve of 0.982 in cohort 1 (sensitivity 0.970, specificity 0.940) and 0.934 in cohort 2 (sensitivity 0.942, specificity 0.791).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The disturbed pathways and biomarker candidates identified in this study may provide novel insights into ALS pathogenesis and improve diagnostic strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cm9.0000000000003874","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T16:04:11Z","timestamp":1765814651000},"page":"610-619","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Untargeted metabolomics based on LC-MS and GC-MS reveal metabolic reprogramming and putative biomarkers in amyotrophic lateral sclerosis"],"prefix":"10.1097","volume":"139","author":[{"given":"Xiaojiao","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Neurology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China"},{"name":"Institution of Neurology, Sichuan Academy of Sciences-Sichuan Provincial Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan 611731, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinming","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Neurology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200020, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shanghai Jiaotong University Affiliated Sixth People\u2019s Hospital, Shanghai 200233, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianbai","family":"Li","sequence":"additional","affiliation":[{"name":"Key Laboratory of Liaoning Province for Research on the Pathogenic Mechanisms of Neurological Diseases, the First Affiliated Hospital, Dalian Medical University, Dalian, Liaoning 116021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Niu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Liaoning Province for Research on the Pathogenic Mechanisms of Neurological Diseases, the First Affiliated Hospital, Dalian Medical University, Dalian, Liaoning 116021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guowang","family":"Xu","sequence":"additional","affiliation":[{"name":"CAS Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, Liaoning 116023 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200020, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Shao","sequence":"additional","affiliation":[{"name":"Key Laboratory of Liaoning Province for Research on the Pathogenic Mechanisms of Neurological Diseases, the First Affiliated Hospital, Dalian Medical University, Dalian, Liaoning 116021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Le","sequence":"additional","affiliation":[{"name":"Key Laboratory of Liaoning Province for Research on the Pathogenic Mechanisms of Neurological Diseases, the First Affiliated Hospital, Dalian Medical University, Dalian, Liaoning 116021, China"},{"name":"Department of Neurology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"R1-20260220","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40035-021-00250-5","article-title":"A perspective on therapies for amyotrophic lateral sclerosis: can disease progression be curbed?","volume":"10","author":"Xu","year":"2021","journal-title":"Transl Neurodegener"},{"key":"R2-20260220","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1474-4422(21)00414-2","article-title":"Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis","volume":"21","author":"Goutman","year":"2022","journal-title":"Lancet Neurol"},{"key":"R3-20260220","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1152\/physrev.00035.2018","article-title":"Metabolomics for investigating physiological and pathophysiological processes","volume":"99","author":"Wishart","year":"2019","journal-title":"Physiol Rev"},{"key":"R4-20260220","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41580-019-0108-4","article-title":"Identification of bioactive metabolites using activity metabolomics","volume":"20","author":"Rinschen","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R5-20260220","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/CM9.0000000000003627","article-title":"Lipid metabolism in health and disease: Mechanistic and therapeutic insights for Parkinson\u2019s disease","volume":"138","author":"Qin","year":"2025","journal-title":"Chin Med J"},{"key":"R6-20260220","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.3390\/biomedicines9121944","article-title":"Altered metabolic profiles of the plasma of patients with amyotrophic lateral sclerosis","volume":"9","author":"Chang","year":"2021","journal-title":"Biomedicines"},{"key":"R7-20260220","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1007\/s12035-016-0078-x","article-title":"Omics to explore amyotrophic lateral sclerosis evolution: the central role of arginine and proline metabolism","volume":"54","author":"Patin","year":"2017","journal-title":"Mol Neurobiol"},{"key":"R8-20260220","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1021\/pr400376e","article-title":"Metabolomics in cerebrospinal fluid of patients with amyotrophic lateral sclerosis: An untargeted approach via high-resolution mass spectrometry","volume":"12","author":"Blasco","year":"2013","journal-title":"J Proteome Res"},{"key":"R9-20260220","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-00312-8","article-title":"Characteristics of serum metabolites in sporadic amyotrophic lateral sclerosis patients based on gas chromatography-mass spectrometry","volume":"11","author":"Jia","year":"2021","journal-title":"Sci Rep"},{"key":"R10-20260220","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.talanta.2017.03.103","article-title":"Capillary electrophoresis tandem mass spectrometry determination of glutamic acid and homocysteine\u2019s metabolites: Potential biomarkers of amyotrophic lateral sclerosis","volume":"170","author":"Cieslarova","year":"2017","journal-title":"Talanta"},{"key":"R11-20260220","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.cca.2010.01.016","article-title":"Metabolomic analysis of serum by (1) H NMR spectroscopy in amyotrophic lateral sclerosis","volume":"411","author":"Kumar","year":"2010","journal-title":"Clin Chim Acta"},{"key":"R12-20260220","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"R13-20260220","doi-asserted-by":"crossref","first-page":"5715","DOI":"10.1021\/pr5007069","article-title":"Serum metabolomics study and eicosanoid analysis of childhood atopic dermatitis based on liquid chromatography-mass spectrometry","volume":"13","author":"Huang","year":"2014","journal-title":"J Proteome Res"},{"key":"R14-20260220","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1074\/mcp.M115.052381","article-title":"Integration of metabolomics and transcriptomics reveals major metabolic pathways and potential biomarker involved in prostate cancer","volume":"15","author":"Ren","year":"2016","journal-title":"Mol Cell Proteomics"},{"key":"R15-20260220","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ijc.31313","article-title":"Metabolomics and transcriptomics profiles reveal the dysregulation of the tricarboxylic acid cycle and related mechanisms in prostate cancer","volume":"143","author":"Shao","year":"2018","journal-title":"Int J Cancer"},{"key":"R16-20260220","doi-asserted-by":"crossref","first-page":"7635","DOI":"10.1021\/acs.analchem.8b01482","article-title":"Comprehensive strategy to construct in-house database for accurate and batch identification of small molecular metabolites","volume":"90","author":"Zhao","year":"2018","journal-title":"Anal Chem"},{"key":"R17-20260220","doi-asserted-by":"crossref","first-page":"6729","DOI":"10.1021\/ac051080y","article-title":"Fusion of mass spectrometry-based metabolomics data","volume":"77","author":"Smilde","year":"2005","journal-title":"Anal Chem"},{"key":"R18-20260220","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106110","article-title":"Integrative analysis of metabolomics and proteomics unravels purine metabolism dysregulation in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis","volume":"181","author":"Xu","year":"2023","journal-title":"Neurobiol Dis"},{"key":"R19-20260220","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202002450R","article-title":"Glucose clearance and uptake is increased in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis through an insulin-independent mechanism","volume":"35","author":"McDonald","year":"2021","journal-title":"FASEB J"},{"key":"R20-20260220","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00401-018-1835-x","article-title":"Energy metabolism in ALS: An underappreciated opportunity?","volume":"135","author":"Vandoorne","year":"2018","journal-title":"Acta Neuropathol"},{"key":"R21-20260220","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.4103\/0366-6999.211549","article-title":"Diets for Patients with amyotrophic lateral sclerosis: Pay attention to nutritional intervention","volume":"130","author":"Yang","year":"2017","journal-title":"Chin Med J"},{"key":"R22-20260220","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.semcancer.2005.04.003","article-title":"Plasma free amino acid profile in cancer patients","volume":"15","author":"Lai","year":"2005","journal-title":"Semin Cancer Biol"},{"key":"R23-20260220","doi-asserted-by":"crossref","first-page":"C58","DOI":"10.1152\/ajpcell.00106.2021","article-title":"Burn-induced hypermetabolism and skeletal muscle dysfunction","volume":"321","author":"Knuth","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"R24-20260220","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1212\/WNL.32.5.550","article-title":"Skeletal muscle catabolism in amyotrophic lateral sclerosis and chronic spinal muscular atrophy","volume":"32","author":"Corbett","year":"1982","journal-title":"Neurology"},{"key":"R25-20260220","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-physiol-020518-114455","article-title":"Branched chain amino acids","volume":"81","author":"Neinast","year":"2019","journal-title":"Annu Rev Physiol"},{"key":"R26-20260220","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ccell.2019.12.011","article-title":"Emerging roles for branched-chain amino acid metabolism in cancer","volume":"37","author":"Sivanand","year":"2020","journal-title":"Cancer Cell"},{"key":"R27-20260220","article-title":"Potential roles of branched-chain amino acids in neurodegeneration","volume":"103\u2013104","author":"Yoo","year":"2022","journal-title":"Nutrition"},{"key":"R28-20260220","doi-asserted-by":"crossref","first-page":"954","DOI":"10.3390\/ijms19040954","article-title":"Branched chain amino acids: Beyond nutrition metabolism","volume":"19","author":"Nie","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R29-20260220","doi-asserted-by":"crossref","first-page":"6747","DOI":"10.1038\/s41388-020-01480-z","article-title":"Multifaceted role of branched-chain amino acid metabolism in cancer","volume":"39","author":"Peng","year":"2020","journal-title":"Oncogene"},{"key":"R30-20260220","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1212\/WNL.53.1.71","article-title":"1H-MRS evidence of neurodegeneration and excess glutamate + glutamine in ALS medulla","volume":"53","author":"Pioro","year":"1999","journal-title":"Neurology"},{"key":"R31-20260220","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108275","article-title":"Targeting mGluR2\/3 for treatment of neurodegenerative and neuropsychiatric diseases","volume":"239","author":"Li","year":"2022","journal-title":"Pharmacol Ther"},{"key":"R32-20260220","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1042\/BST20130220","article-title":"The serine shuttle between glia and neurons: implications for neurotransmission and neurodegeneration","volume":"41","author":"Wolosker","year":"2013","journal-title":"Biochem Soc Trans"},{"key":"R33-20260220","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1146\/annurev.biochem.69.1.617","article-title":"Aminoacyl-tRNA synthesis","volume":"69","author":"Ibba","year":"2000","journal-title":"Annu Rev Biochem"},{"key":"R34-20260220","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s12276-022-00765-5","article-title":"Functional and pathologic association of aminoacyl-tRNA synthetases with cancer","volume":"54","author":"Sung","year":"2022","journal-title":"Exp Mol Med"},{"key":"R35-20260220","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.abb3414","article-title":"The integrated stress response contributes to tRNA synthetase-associated peripheral neuropathy","volume":"373","author":"Spaulding","year":"2021","journal-title":"Science"},{"key":"R36-20260220","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1126\/science.abb3356","article-title":"tRNA overexpression rescues peripheral neuropathy caused by mutations in tRNA synthetase","volume":"373","author":"Zuko","year":"2021","journal-title":"Science"},{"key":"R37-20260220","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.1038\/s41467-023-41511-3","article-title":"Phenylalanine-tRNA aminoacylation is compromised by ALS\/FTD-associated C9orf72 C4G2 repeat RNA","volume":"14","author":"Malnar \u010crnigoj","year":"2023","journal-title":"Nat Commun"},{"key":"R38-20260220","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/ng0197-91","article-title":"Mutations in SOD1 associated with amyotrophic lateral sclerosis cause novel protein interactions","volume":"15","author":"Kunst","year":"1997","journal-title":"Nat Genet"},{"key":"R39-20260220","doi-asserted-by":"crossref","first-page":"11043","DOI":"10.1073\/pnas.0802862105","article-title":"Aminoacyl tRNA synthetases and their connections to disease","volume":"105","author":"Park","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"R40-20260220","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1177\/1535370215584931","article-title":"Inosine and hypoxanthine as novel biomarkers for cardiac ischemia: From bench to point-of-care","volume":"240","author":"Farthing","year":"2015","journal-title":"Exp Biol Med (Maywood)"},{"key":"R41-20260220","article-title":"Hypoxanthine is a pharmacodynamic marker of ischemic brain edema modified by glibenclamide","volume":"3","author":"Irvine","year":"2022","journal-title":"Cell Rep Med"},{"key":"R42-20260220","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/cvr\/27.8.1498","article-title":"Interstitial purine metabolites and lactate during regional myocardial hypoxia","volume":"27","author":"Van Wylen","year":"1993","journal-title":"Cardiovasc Res"},{"key":"R43-20260220","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000242852","article-title":"Concentration of hypoxanthine in both cerebrospinal fluid and brain tissue increases under intensive hypoxia only","volume":"54","author":"Lun","year":"1988","journal-title":"Biol Neonate"},{"key":"R44-20260220","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1136\/jnnp.45.6.552","article-title":"Forearm exercise increases plasma hypoxanthine","volume":"45","author":"Patterson","year":"1982","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R45-20260220","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.2174\/1381612822666160210144419","article-title":"Xanthine oxidase pathway and muscle damage. Insights from McArdle disease","volume":"22","author":"Pareja-Galeano","year":"2016","journal-title":"Curr Pharm Des"},{"key":"R46-20260220","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/13510002.2022.2051964","article-title":"Serum uric acid level predicts the progression of amyotrophic lateral sclerosis following treatment with edaravone","volume":"27","author":"Han","year":"2022","journal-title":"Redox Rep"},{"key":"R47-20260220","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2023.148445","article-title":"Gender-specific association of uric acid and survival in sporadic amyotrophic lateral sclerosis patients","volume":"1815","author":"Bai","year":"2023","journal-title":"Brain Res"},{"key":"R48-20260220","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s11011-014-9510-y","article-title":"Serum uric acid level is associated with the prevalence but not with survival of amyotrophic lateral sclerosis in a Chinese population","volume":"29","author":"Zheng","year":"2014","journal-title":"Metab Brain Dis"},{"key":"R49-20260220","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101882","article-title":"Xanthine oxidoreductase: One enzyme for multiple physiological tasks","volume":"41","author":"Bortolotti","year":"2021","journal-title":"Redox Biol"},{"key":"R50-20260220","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1007\/s12035-016-9866-6","article-title":"Hypoxanthine intrastriatal administration alters neuroinflammatory profile and redox status in striatum of infant and young adult rats","volume":"54","author":"Biasibetti","year":"2017","journal-title":"Mol Neurobiol"},{"key":"R51-20260220","first-page":"4098","article-title":"Hypoxanthine induces neuroenergetic impairment and cell death in striatum of young adult Wistar rats","volume":"55","author":"Biasibetti-Brendler","year":"2018","journal-title":"Mol Neurobiol"},{"key":"R52-20260220","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1523\/JNEUROSCI.6554-10.2012","article-title":"Reduced activity of AMP-activated protein kinase protects against genetic models of motor neuron disease","volume":"32","author":"Lim","year":"2012","journal-title":"J Neurosci"},{"issue":"Pt A","key":"R53-20260220","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.expneurol.2017.08.013","article-title":"AMPK activation: Role in the signaling pathways of neuroinflammation and neurodegeneration","volume":"298","author":"Peixoto","year":"2017","journal-title":"Exp Neurol"},{"key":"R54-20260220","first-page":"170","article-title":"Neuroprotective effect of allopurinol and nimesulide against cerebral ischemic reperfusion injury in diabetic rats","volume":"17","author":"Ansari","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R55-20260220","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.pharmthera.2016.12.004","article-title":"Allopurinol as a therapeutic option in cardiovascular disease","volume":"172","author":"Okafor","year":"2017","journal-title":"Pharmacol Ther"},{"key":"R56-20260220","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1172\/JCI113288","article-title":"Allopurinol enhanced adenine nucleotide repletion after myocardial ischemia in the isolated rat heart","volume":"81","author":"Lasley","year":"1988","journal-title":"J Clin Invest"},{"key":"R57-20260220","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/jnen\/nlw088","article-title":"New strategy that delays progression of amyotrophic lateral sclerosis in G1H-G93A transgenic mice: Oral administration of xanthine oxidoreductase inhibitors that are not substrates for the purine salvage pathway","volume":"75","author":"Kato","year":"2016","journal-title":"J Neuropathol Exp Neurol"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003874","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T05:00:54Z","timestamp":1771563654000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000003874","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"2025-05-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}